You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: May 23, 2024

Actavis Labs Fl Inc Company Profile


✉ Email this page to a colleague

« Back to Dashboard


What is the competitive landscape for ACTAVIS LABS FL INC, and what generic and branded alternatives to ACTAVIS LABS FL INC drugs are available?

ACTAVIS LABS FL INC has seventy approved drugs.

There are six tentative approvals on ACTAVIS LABS FL INC drugs.

Summary for Actavis Labs Fl Inc
US Patents:0
Tradenames:58
Ingredients:56
NDAs:70

Drugs and US Patents for Actavis Labs Fl Inc

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Actavis Labs Fl Inc MIRTAZAPINE mirtazapine TABLET, ORALLY DISINTEGRATING;ORAL 076307-002 Dec 17, 2003 DISCN No No ⤷  Sign Up ⤷  Sign Up
Actavis Labs Fl Inc RISPERIDONE risperidone TABLET, ORALLY DISINTEGRATING;ORAL 076996-003 Apr 19, 2011 DISCN No No ⤷  Sign Up ⤷  Sign Up
Actavis Labs Fl Inc ALPRAZOLAM alprazolam TABLET, EXTENDED RELEASE;ORAL 077198-004 May 13, 2010 DISCN No No ⤷  Sign Up ⤷  Sign Up
Actavis Labs Fl Inc TROSPIUM CHLORIDE trospium chloride CAPSULE, EXTENDED RELEASE;ORAL 091289-001 Oct 12, 2012 AB RX No Yes ⤷  Sign Up ⤷  Sign Up
Actavis Labs Fl Inc DOXYCYCLINE HYCLATE doxycycline hyclate CAPSULE;ORAL 062031-001 Approved Prior to Jan 1, 1982 AB RX No No ⤷  Sign Up ⤷  Sign Up
Actavis Labs Fl Inc TAMOXIFEN CITRATE tamoxifen citrate TABLET;ORAL 070929-001 Feb 20, 2003 AB RX No No ⤷  Sign Up ⤷  Sign Up
Actavis Labs Fl Inc RISPERIDONE risperidone TABLET, ORALLY DISINTEGRATING;ORAL 076996-004 Apr 19, 2011 DISCN No No ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Paragraph IV (Patent) Challenges for ACTAVIS LABS FL INC drugs
Drugname Dosage Strength Tradename Submissiondate
➤ Subscribe Delayed-release Tablets 20 mg ➤ Subscribe 2015-06-03
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.